Immunologie :
Autres spécialités
MENU
Se connecter / S'inscrire
Se connecter / S'inscrire

    • {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}
      • écho dans les mici
      écho dans les mici

        

      génération des images
      génération des images

      Tout d’abord, il n’existe pas de recommandations quant au nombre d’examens d’échographie intestinale nécessaires pour devenir un spécialiste. Cela dépend beaucoup de la connaissance globale de l’échographie abdominale générale, de l’expertise locale, par exemple, si un confrère chevronné est disponible pour discuter avec vous des problèmes que vous rencontrez ou des questions que vous vous posez.

      Naturellement, la connaissance de la terminologie est essentielle. 

      ECHO-MICI-FR-GASTRO-FORMATION-IMG-ABBVIEPRO

      Plusieurs publications récentes sont disponibles sur le sujet, par exemple :

      • Maconi G et al. EFSUMB Recommendations and Clinical Guidelines for Intestinal Ultrasound (GIUS) in Infammatory Bowel Diseases. Ultraschall Med. 2018 Jun;39(3):304-317.
      • Bryant RV et al. Gastrointestinal ultrasound in infammatory bowel disease: an underused resource with potential paradigm-changing application. Gut. 2018 May;67(5):973-985.
      • Atkinson NSS et al. How to perform gastrointestinal ultrasonography: Anatomy and normal findings. World J Gastroenterol. 2017 Oct 14;23(38):6931-6941.
      • Nylund K et al. EFSUMB Recommendations and Guidelines for Gastrointestinal Ultrasound. Ultraschall Med. 2017 Jun;38(3):273-284.
      • Kucharzik T, Maaser C Intestinal ultrasound and management of small bowel Crohn’s disease. Therap Adv Gastroenterol. 2018;11:1-13.
      • Kucharzik T et al. Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity. Clin Gastroenterol Hepatol. 2017;15:535-542.
      1. Bryant RV et al. Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application. Gut. 2018; 67(5):973- 985.
      2. Nylund K et al. EFSUMB Recommendations and Guidelines for Gastrointestinal Ultrasound. Ultraschall Med. 2017;38(3):273-284.
      3. Sturm A et al., European Crohn’s and Colitis Organisation [ECCO]; European Society of Gastrointestinal and Abdominal Radiology [ESGAR]. J Crohns Colitis 2018,1-18 Epub ahead of print.
      4. Socaciu M et al. Non-Invasive Assessment of Inflammation and Treatment Response in Patients with Crohn‘s Disease and Ulcerative Colitis using Contrast-Enhanced Ultrasonography Quantification. J Gastrointestin Liver Dis. 2015;24(4):457-65.
      5. Kucharzik T, Maaser C Intestinal ultrasound and management of small bowel Crohn‘s disease. Therap Adv Gastroenterol. 2018;11:1-13
      6. Calabrese E et al. Accuracy of small-intestine contrast ultrasonography, compared with computed tomography enteroclysis, in characterizing lesions in patients with Crohn‘s disease. Clin Gastroenterol Hepatol. 2013;11(8):950-5.
      7. Maaser C et al. ECCO-ESGAR Guideline for Diagnostic Assessment in Inflammatory Bowel Disease. J Crohns Colitis 2018, 1-32 Epub ahead of print. 
      8. Kratzer W et al. Contrast-enhanced power Doppler sonography of the intestinal wall in the differentiation of hypervascularized and hypovascularized intestinal obstructions in patients with Crohn‘s disease. J Ultrasound Med. 2002;21(2):149-57;158-9.
      9. Ripollés T et al. Contrast-enhanced ultrasound in the differentiation between phlegmon and abscess in Crohn‘s disease and other abdominal conditions. Eur J Radiol. 2013;82(10):e525-31.
      10. Ripollés T et al. Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn‘s disease: a comparison with surgical histopathology analysis. J Crohns Colitis. 2013;7(2):120-8.

      FR-IMMG-210087 - 01/2022

      Information Médicale et Scientifique 

      Pour toute question sur les médicaments AbbVie et leurs environnements, vous pouvez contacter le service d’Information Médicale et Scientifique au 0 800 001 289 ou France.infomed@abbvie.com